Tuesday, Apr 23 2024 | Time 14:28 Hrs(IST)
image
Business EconomyPosted at: Oct 19 2020 11:15AM


Glenmark Pharmaceuticals receives ANDA approval for Sirolimus Tablets, 0.5 mg, 1 mg and 2 mg

MUMBAI, India, Oct. 19, 2020 /PRNewswire/ -- Glenmark Pharmaceuticals Inc., USA (Glenmark) has received final approval by the United States Food & Drug Administration (U.S. FDA) for Sirolimus Tablets, 0.5 mg, 1 mg and 2 mg, the generic version of Rapamune®1 Tablets, 0.5 mg, 1 mg and 2 mg, of PF Prism CV.
According to IQVIATM sales data for the 12 month period ending August 2020, the Rapamune® Tablets, 0.5 mg, 1 mg and 2 mg market2 achieved annual sales of approximately $119.7 million*.
Glenmark's current portfolio consists of 165 products authorized for distribution in the U.S. marketplace and 45 ANDA's pending approval with the U.S. FDA. In addition to these internal filings, Glenmark continues to identify and explore external development partnerships to supplement and accelerate the growth of its existing pipeline and portfolio.
1 All brand names and trademarks are the property of their respective owners.
2 Market includes brand and all available therapeutic equivalents
* IQVIATM National Sales Perspectives: Retail & Non-Retail, August 2020
About Glenmark Pharmaceuticals Ltd
Glenmark Pharmaceuticals Ltd. (GPL) is a global research-led pharmaceutical company with presence across Generics, Specialty and OTC business with operations in over 50 countries. Glenmark's key therapy focus areas globally are respiratory, dermatology and oncology. It is ranked among the top 80 Pharma & Biotech companies of the world in terms of revenue (SCRIP 100 Rankings published in the year 2019). For more information, visit www.glenmarkpharma.com.
Logo: http://mma.prnewswire.com/media/451507/PRNE_Glenmark_Logo.jpg
(Disclaimer--Features may vary depending on the regions; subject to change without notice.)
Please log in to get detailed story.
Tags: #Glenmark Pharmaceuticals receives ANDA approval for Sirolimus Tablets# 0.5 mg# 1 mg and 2 mg
More News
Rupee rises 3 paise against USD

Rupee rises 3 paise against USD

23 Apr 2024 | 11:35 AM

Mumbai, Apr 23 (UNI) The rupee continued to rise on Tuesday too, as it advanced 3 paise to 83.34 in the opening session on the selling of US dollars by bankers and exporters, dealers at the Foreign Exchange said.

see more..
Sensex up 400 points

Sensex up 400 points

23 Apr 2024 | 11:35 AM

Mumbai, Apr 23 (UNI) Extending the rally for the third consecutive day, the BSE Sensex on Tuesday spurted 400 points to open at 74,048.94 as buying was seen across the board.

see more..
Air India and All Nippon Airways to begin codeshare partnership for travel between India and Japan

Air India and All Nippon Airways to begin codeshare partnership for travel between India and Japan

23 Apr 2024 | 11:19 AM

GURUGRAM, Apr 23 (UNI) Air India, India’s leading global airline, and All Nippon Airways, the largest Japanese carrier, have signed a codeshare agreement connecting their networks.

see more..

Major Currencies down

23 Apr 2024 | 10:29 AM

Mumbai, Apr 23 (UNI) Following were the indicative currency rates and travellers' cheques
buying and selling rates.

see more..

RINL-VSP seeks help from all stakeholders in resolving severe coal crisis

22 Apr 2024 | 8:28 PM

Visakhapatnam (Andhra Pradesh), April 22 (UNI) In the backdrop of a severe coal crisis due to the halt in operations at Adani Gangavaram Port Limited (AGPL), Rashtriya Ispat Nigam Limited (RINL), popularly known as Visakhapatnam Steel Plant (VSP), on Monday requested all citizens, stakeholders, contract workers, and people's representatives to come together and assist the plant in resolving the coal crisis.

see more..
image